Ignite Creation Date:
2025-12-24 @ 9:16 PM
Ignite Modification Date:
2026-01-04 @ 4:57 AM
Study NCT ID:
NCT05999604
Status:
RECRUITING
Last Update Posted:
2025-09-29
First Post:
2023-08-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Impact of Annual Versus Biannual Infusions of Ocrelizumab in Patients With Active MS,After 2 Years of Initial Treatment, on Freedom From Radiological Disease Activity at Two Years: a Multicenter Randomized Controlled Non-inferiority Trial
Sponsor:
Fondation Ophtalmologique Adolphe de Rothschild
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
CBR_2022_13
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None